Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Final Hemophilia Drug Policies .

print Print Back Back Hemophilia Products - Factor VIII Prior Authorization Program Summary Policy Number:...

print Print Back Back Hemophilia Products - Anti-Inhibitor Coagulant Complex: Feiba NF/Feiba VF Policy...

print Print Back Back Hemophilia Products - Coagulation Factor XIII A-subunit: Tretten Policy Number: PH-0338...

Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Profilnine, Rebinyn, and Rixubis

Advate, Adynovate, Afstyla, Eloctate, Hemofil M, Koate DVI, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Obizur, Recombinate, Xyntha/Xyntha Solofuse, Jivi, Esperoct, Altuviiio

print Print Back Back Hemophilia Products - Factor X: Coagadex Policy Number: PH-0341 Intravenous ...

print Print Back Back Hemophilia Products - Factor XIII: Corifact Policy Number: PH-0342 Intravenous ...

print Print Back Back Hemophilia Products – Factor VIIa: NovoSeven RT ®; Sevenfact ® Policy Number: PH-0343 ...

print Print Back Back Hemophilia Products – von Willebrand Factor: Vonvendi® Policy Number: PH-0344 ...

print Print Back Back Hemophilia Products – Factor VIII/VWF Complex: Alphanate, Humate-P®, Wilate Policy...

print Print Back Back Hemophilia Products – Anti-Inhibitor Antibody: Hemlibra ® (emicizumab-kxwh) Policy...